Skip to main content
SpringerLink
Log in

Diagnosis and Evaluation of Cholangiocarcinoma

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 703 Accesses

Abstract

Cholangiocarcinoma is a malignancy of the biliary tree with a poor 5-year survival. Because of the aggressive nature of the cancer and its tendency to present at advanced stages, making an early and accurate diagnosis is paramount to optimizing outcomes. Cholangiocarcinomas are classified based on their anatomic location as intrahepatic, perihilar, or distal. These types of cholangiocarcinomas are distinct in their presentations and warrant different approaches to diagnosis and management. Diagnosis can be made by integrating the clinical presentation, tumor markers, radiological appearance and histology. Physicians often face several challenges during the workup and diagnosis of cholangiocarcinoma. While tumor markers can lack of sensitivity and specificity, radiological imaging sometimes fails to distinguish cholangiocarcinoma from hepatocellular carcinoma or non-malignant diseases. Another challenge is the difficulty of acquiring a sufficient tissue sample for diagnosis. The aim of this chapter is to review the clinical and laboratory findings of cholangiocarcinoma in addition to different imaging modalities and tissue acquisition methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Clinic C. Current clinical medicine e-book: expert consult – online. Elsevier Health Sciences. Maryland Heights, MO; 2010.

    Google Scholar 

  2. Kirstein MM, Vogel A. Epidemiology and risk factors of cholangiocarcinoma. Visc Med. 2016;32:395–400.

    Google Scholar 

  3. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303–14.

    Google Scholar 

  4. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepato-Biliary-Pancreat Surg. 2003;10:288–91.

    Google Scholar 

  5. Mafi P, Chu QD, Smith RR, Gibbs JF. Cholangiocarcinoma. In: Chu QD, Gibbs JF, Zibari GB, editors. Surgical oncology: a practical and comprehensive approach. New York: Springer; 2015. p. 257–82.

    Google Scholar 

  6. Rekman JF, Rocha FG. Staging and prognosis. In: Pawlik TM, Cloyd JM, Dillhoff M, editors. Intrahepatic cholangiocarcinoma: diagnosis and management. Cham: Springer International Publishing; 2019. p. 21–51.

    Google Scholar 

  7. Gamblin TC. Surgical oncology clinics, an issue of surgical oncology clinics of North America, ebook. Elsevier Health Sciences. Maryland Heights, MO; 2019.

    Google Scholar 

  8. Papafragkakis C, Lee J. Comprehensive management of cholangiocarcinoma: part I. Diagnosis. Int J Gastrointest Interv. 2017;6:85–93.

    Google Scholar 

  9. Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol. 2010;25:1485–92.

    Google Scholar 

  10. Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261–80.

    Google Scholar 

  11. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–73; Discussion 473–465.

    CAS  Google Scholar 

  12. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol. 1999;25:375–80.

    Google Scholar 

  13. Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schonleben F. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year western single-center experience in 107 patients. Ann Surg Oncol. 2009;16:404–12.

    Google Scholar 

  14. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg. 2007;31:2016–22.

    Google Scholar 

  15. Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, et al. Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “cholangiocarcinoma” committee of the Italian association for the study of liver disease. Dig Liver Dis. 2011;43:60–5.

    Google Scholar 

  16. Singh S, Tang SJ, Sreenarasimhaiah J, Lara LF, Siddiqui A. The clinical utility and limitations of serum carbohydrate antigen (ca19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. Dig Dis Sci. 2011;56:2491–6.

    CAS  Google Scholar 

  17. Leelawat K, Narong S, Wannaprasert J, Ratanashu-ek T. Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma. World J Gastroenterol. 2010;16:4697–703.

    CAS  Google Scholar 

  18. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of ca 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:204–7.

    CAS  Google Scholar 

  19. Pawlik TM, Cloyd JM, Dillhoff M. Intrahepatic cholangiocarcinoma: diagnosis and management. Springer International Publishing. Columbus Ohio; 2019.

    Google Scholar 

  20. Xu HX, Chen LD, Liu LN, Zhang YF, Guo LH, Liu C. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Br J Radiol. 2012;85:1029–37.

    Google Scholar 

  21. Colli A, Cocciolo M, Mumoli N, Cesarini L, Prisco A, Gaffuri I, et al. Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound. 1998;7:93–9.

    CAS  Google Scholar 

  22. Fabrega-Foster K, Ghasabeh MA, Pawlik TM, Kamel IR. Multimodality imaging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6:67–78.

    Google Scholar 

  23. Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol. 1992;158:77–9.

    CAS  Google Scholar 

  24. Suthar M, Purohit S, Bhargav V, Goyal P. Role of mrcp in differentiation of benign and malignant causes of biliary obstruction. J Clin Diagn Res. 2015;9:TC08–12.

    Google Scholar 

  25. Jhaveri KS, Hosseini-Nik H. MRI of cholangiocarcinoma. J Magn Reson Imaging. 2015;42:1165–79.

    Google Scholar 

  26. Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657–69.

    CAS  Google Scholar 

  27. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose pet imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–7.

    Google Scholar 

  28. Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD. Usefulness of 18f-fdg pet in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. 2003;30:1467–72.

    Google Scholar 

  29. Fevery J, Buchel O, Nevens F, Verslype C, Stroobants S, Van Steenbergen W. Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol. 2005;43:358–60.

    Google Scholar 

  30. Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D’Angelica M, Fong Y, et al. 18f-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57–65.

    Google Scholar 

  31. Lee SW, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, et al. Clinical usefulness of 18f-fdg pet-ct for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol. 2010;45:560–6.

    Google Scholar 

  32. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.

    Google Scholar 

  33. Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17:669–80.

    Google Scholar 

  34. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215:31–8.

    CAS  Google Scholar 

  35. Rizvi S, Gores GJ. Current diagnostic and management options in perihilar cholangiocarcinoma. Digestion. 2014;89:216–24.

    CAS  Google Scholar 

  36. Hadjis NS, Adam A, Gibson R, Blenkharn JI, Benjamin IS, Blumgart LH. Nonoperative approach to hilar cancer determined by the atrophy-hypertrophy complex. Am J Surg. 1989;157:395–9.

    CAS  Google Scholar 

  37. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308–21.

    CAS  Google Scholar 

  38. Fitzgerald JE, White MJ, Lobo DN. Courvoisier’s gallbladder: law or sign? World J Surg. 2009;33:886–91.

    Google Scholar 

  39. Rahnemai-Azar AA, Collins KM, Fowler KJ, Chapman WC. Perihilar cholangiocarcinoma. In: Morita SY, Balch CM, Klimberg VS, Pawlik TM, Posner MC, Tanabe KK, editors. Textbook of complex general surgical oncology. New York: McGraw-Hill Education; 2018.

    Google Scholar 

  40. Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14:4131–6.

    Google Scholar 

  41. Hann LE, Greatrex KV, Bach AM, Fong Y, Blumgart LH. Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol. 1997;168:985–9.

    CAS  Google Scholar 

  42. Xu HX, Chen LD, Xie XY, Xie XH, Xu ZF, Liu GJ, et al. Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. Eur J Radiol. 2010;75:197–202.

    Google Scholar 

  43. Seo H, Lee JM, Kim IH, Han JK, Kim SH, Jang JY, et al. Evaluation of the gross type and longitudinal extent of extrahepatic cholangiocarcinomas on contrast-enhanced multidetector row computed tomography. J Comput Assist Tomogr. 2009;33:376–82.

    Google Scholar 

  44. Gore RM, Levine MS. Neoplasms of the gallbladder and biliary tract. In: Textbook of gastrointestinal radiology e-book. 4th ed. Elsevier Health Sciences; 2014. p. 1402–26.

    Google Scholar 

  45. Yin XY. Diagnosis. In: Lau WY, editor. Hilar cholangiocarcinoma. Dordrecht: Springer Netherlands. Springer Dordrecht Heidelberg New York London; 2013. p. 91–8.

    Google Scholar 

  46. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990–2009. World J Gastroenterol. 2009;15:4240–62.

    CAS  Google Scholar 

  47. Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, et al. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR Am J Roentgenol. 1999;172:73–7.

    CAS  Google Scholar 

  48. Watadani T, Akahane M, Yoshikawa T, Ohtomo K. Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings. Radiat Med. 2008;26:402–7.

    Google Scholar 

  49. Vilgrain V. Staging cholangiocarcinoma by imaging studies. HPB (Oxford). 2008;10:106–9.

    CAS  Google Scholar 

  50. Choi JY, Kim MJ, Lee JM, Kim KW, Lee JY, Han JK, et al. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol. 2008;191:1448–57.

    Google Scholar 

  51. Ruys AT, van Beem BE, Engelbrecht MR, Bipat S, Stoker J, Van Gulik TM. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol. 2012;85:1255–62.

    CAS  Google Scholar 

  52. Singh A, Mann HS, Thukral CL, Singh NR. Diagnostic accuracy of MRCP as compared to ultrasound/CT in patients with obstructive jaundice. J Clin Diagn Res. 2014;8:103–7.

    Google Scholar 

  53. Waxman I, Gonzalez-Haba M. Assessment of bile duct tumors: endoscopic vs radiographic. In: Millis JM, Matthews JB, editors. Difficult decisions in hepatobiliary and pancreatic surgery: an evidence-based approach. Cham: Springer International Publishing; 2016. p. 329–39.

    Google Scholar 

  54. Rosch T, Meining A, Fruhmorgen S, Zillinger C, Schusdziarra V, Hellerhoff K, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc. 2002;55:870–6.

    Google Scholar 

  55. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233:234–40.

    Google Scholar 

  56. Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol. 2004;99:45–51.

    CAS  Google Scholar 

  57. Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:244–52.

    Google Scholar 

  58. Rosch T, Hofrichter K, Frimberger E, Meining A, Born P, Weigert N, et al. Ercp or eus for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc. 2004;60:390–6.

    Google Scholar 

  59. Weber A, von Weyhern C, Fend F, Schneider J, Neu B, Meining A, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol. 2008;14:1097–101.

    Google Scholar 

  60. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004;2:214–9.

    Google Scholar 

  61. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc. 2006;64:325–33.

    Google Scholar 

  62. Mohamadnejad M, DeWitt JM, Sherman S, LeBlanc JK, Pitt HA, House MG, et al. Role of eus for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointest Endosc. 2011;73:71–8.

    Google Scholar 

  63. Korc P, Sherman S. ERCP tissue sampling. Gastrointest Endosc. 2016;84:557–71.

    Google Scholar 

  64. Gupta AK, Garg A, Khandelwal N. Diagnostic radiology: gastrointestinal and hepatobiliary imaging. Jaypee Brothers, Medical Publishers Pvt. Limited; 2017.

    Google Scholar 

  65. Hameed SM, Dixon E. Distal cholangiocarcinoma and periampullary cancer. In: Morita SY, Balch CM, Klimberg VS, Pawlik TM, Posner MC, Tanabe KK, editors. Textbook of complex general surgical oncology. New York: McGraw-Hill Education; 2018.

    Google Scholar 

  66. Lad N, Kooby DA. Distal cholangiocarcinoma. Surg Oncol Clin N Am. 2014;23:265–87.

    Google Scholar 

  67. Schoefl R, Haefner M, Wrba F, Pfeffel F, Stain C, Poetzi R, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol. 1997;32:363–8.

    CAS  Google Scholar 

  68. Moura DTH, de Moura EGH, Matuguma SE, Dos Santos ME, Moura ETH, Baracat FI, et al. EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures: a prospective comparative study. Endosc Int Open. 2018;6:E769–77.

    Google Scholar 

  69. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–6.

    Google Scholar 

  70. Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol. 1997;32:1042–5.

    CAS  Google Scholar 

  71. Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11:13–21. e11; quiz e13–14.

    Google Scholar 

  72. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36:321–7.

    Google Scholar 

  73. Boberg K, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002;37:1205–11.

    CAS  Google Scholar 

  74. Jarnagin WR. Primary sclerosing cholangitis. In: Blumgart’s surgery of the liver, pancreas and biliary tract e-book. Elsevier Health Sciences; 2016. p. 603–14.

    Google Scholar 

  75. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum ca 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Springer Nature, Cham Switzerland: Dig Dis Sci. 2005;50:1734–40.

    Google Scholar 

  76. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108:865–9.

    CAS  Google Scholar 

  77. Lindor KD, Kowdley KV, Harrison ME. American College of G: Acg clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59; quiz 660.

    CAS  Google Scholar 

  78. Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3497–503.

    Google Scholar 

  79. Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features. Gut Liver. 2018;12:17–29.

    CAS  Google Scholar 

  80. Singh A, Siddiqui UD. The role of endoscopy in the diagnosis and management of cholangiocarcinoma. J Clin Gastroenterol. 2015;49:725–37.

    Google Scholar 

  81. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy. 1999;31:712–7.

    CAS  Google Scholar 

  82. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc. 1995;42:520–6.

    CAS  Google Scholar 

  83. Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc. 2006;63:71–7.

    Google Scholar 

  84. de Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 2). Gastrointest Endosc. 2002;56:720–30.

    Google Scholar 

  85. Technology Assessment C, Barkun A, Liu J, Carpenter S, Chotiprasidhi P, Chuttani R, et al. Update on endoscopic tissue sampling devices. Gastrointest Endosc. 2006;63:741–5.

    Google Scholar 

  86. Siddiqui AA, Strongin A, Kistler A, Eloubeidi MA. Equipment and approach. In: Lee LS, editor. ERCP and EUS: a case-based approach. New York: Springer; 2015. p. 357–70.

    Google Scholar 

  87. Al-Haddad MA. Endoscopic ultrasound in bile duct, gallbladder, and ampullary lesions. In: Endosonography. 11th ed; 2019. p. 201–24.

    Google Scholar 

  88. Abe Y, Kawakami H, Oba K, Hayashi T, Yasuda I, Mukai T, et al. Effect of a stylet on a histological specimen in EUS-guided fine-needle tissue acquisition by using 22-gauge needles: a multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. Robert H. Hawes Publisher: Elsevier Saunders, Philadelphia; 2015;82:837–44. e831

    Google Scholar 

  89. Wani S, Gupta N, Gaddam S, Singh V, Ulusarac O, Romanas M, et al. A comparative study of endoscopic ultrasound guided fine needle aspiration with and without a stylet. Dig Dis Sci. 2011;56:2409–14.

    Google Scholar 

  90. Attam R, Arain MA, Bloechl SJ, Trikudanathan G, Munigala S, Bakman Y, et al. “Wet suction technique (west)”: a novel way to enhance the quality of EUS-FNA aspirate. Results of a prospective, single-blind, randomized, controlled trial using a 22-gauge needle for EUS-FNA of solid lesions. Gastrointest Endosc. 2015;81:1401–7.

    Google Scholar 

  91. Karagyozov P, Boeva I, Tishkov I. Role of digital single-operator cholangioscopy in the diagnosis and treatment of biliary disorders. World J Gastrointest Endosc. 2019;11:31–40.

    Google Scholar 

  92. Huang W-H. ERCP for biliary-pancreatic tissue acquisition. In: Lai K-H, Mo L-R, Wang H-P, editors. Biliopancreatic endoscopy: practical application. Singapore: Springer; 2018. p. 107–15.

    Google Scholar 

  93. Draganov PV, Chauhan S, Wagh MS, Gupte AR, Lin T, Hou W, et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc. 2012;75:347–53.

    Google Scholar 

  94. Laleman W, Verraes K, Van Steenbergen W, Cassiman D, Nevens F, Van der Merwe S, et al. Usefulness of the single-operator cholangioscopy system spyglass in biliary disease: a single-center prospective cohort study and aggregated review. Surg Endosc. 2017;31:2223–32.

    Google Scholar 

  95. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004;99:1675–81.

    Google Scholar 

  96. Nguyen K, Sing JT Jr. Review of endoscopic techniques in the diagnosis and management of cholangiocarcinoma. World J Gastroenterol. 2008;14:2995–9.

    Google Scholar 

  97. Harbhajanka A, Michael CW, Janaki N, Gokozan HN, Wasman J, Bomeisl P, et al. Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis. Mod Pathol. 2020:1–7.

    Google Scholar 

  98. Warner SG, Cho CS, Fong Y. Biliary tract tumors. Shackelford’s surgery of the alimentary tract, 2 volume set; 2019. 33:1323–39.

    Google Scholar 

  99. El-Khoueiry A. Uncommon hepatobiliary tumors. In: Textbook of uncommon cancer; 2017. pp. 444–57.

    Google Scholar 

  100. Kim SY. Preoperative radiologic evaluation of cholangiocarcinoma. Korean J Gastroenterol 2017;69:159–63.

    Google Scholar 

  101. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512–22.

    Google Scholar 

  102. Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98–107.

    Google Scholar 

  103. Amin MB, Edge SB. AJCC cancer staging manual. Springer; 2017.

    Google Scholar 

  104. Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. Oak Brook, IL: Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 2008;28:1115–29.

    Google Scholar 

  105. Tsunoda T, Eto T, Yamada M, Tajima Y, Matsuo S, Tsuchiya R, et al. Segmental primary sclerosing cholangitis mimicking bile duct cancer – report of a case and review of the Japanese literature. Jpn J Surg. 1991;21:329–34.

    CAS  Google Scholar 

  106. Stone JH, Zen Y, Deshpande V. Igg4-related disease. N Engl J Med. 2012;366:539–51.

    CAS  Google Scholar 

  107. Suriawinata A. Neoplastic mimics in gastrointestinal and liver pathology. New York: Demos Medical Publishing; 2014.

    Google Scholar 

  108. Lee JJ, Schindera ST, Jang H-J, Fung S, Kim TK. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis. Abdom Radiol. 2017;42:2898–908.

    Google Scholar 

  109. Zen Y, Kawakami H, Kim JH. Igg4-related sclerosing cholangitis: all we need to know. J Gastroenterol. 2016;51:295–312.

    CAS  Google Scholar 

  110. Zhang Y, Lu H, Ji H, Li Y. Inflammatory pseudotumor of the liver: a case report and literature review. Intractable Rare Dis Res. 2015;4:155–8.

    Google Scholar 

  111. Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics. 2003;23:719–29.

    Google Scholar 

  112. Matsuo Y, Sato M, Shibata T, Morimoto M, Tsuboi K, Shamoto T, et al. Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case. World J Surg Oncol. 2014;12:140.

    Google Scholar 

  113. Kassahun W, Stumpp P, Hoffmeister A, Jonas S. Differential diagnosis. In: Lau WY, editor. Hilar cholangiocarcinoma. Dordrecht: Springer; 2013. p. 99–109.

    Google Scholar 

  114. Jessurun J, Pambuccian S. Infectious and inflammatory disorders of the gallbladder and extrahepatic biliary tract. In: Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Elsevier; 2009. p. 823–43.

    Google Scholar 

  115. Giesbrandt KJ, Bulatao IG, Keaveny AP, Nguyen JH, Paz-Fumagalli R, Taner CB. Radiologic characterization of ischemic cholangiopathy in donation-after-cardiac-death liver transplants and correlation with clinical outcomes. Leesburg, VA: AJR Am J Roentgenol. 2015;205:976–84.

    Google Scholar 

  116. Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology. 2006;44:1063–74.

    Google Scholar 

  117. Cappell MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol. 1991;86.

    Google Scholar 

  118. Margulis SJ, Honig CL, Soave R, Govoni AF, Mouradian JA, Jacobson IM. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med. 1986;105:207–10.

    CAS  Google Scholar 

  119. Gao Y, Chin K, Mishriki YY. Aids cholangiopathy in an asymptomatic, previously undiagnosed late-stage hiv-positive patient from Kenya. Int J Hepatol. 2011;2011:465895.

    Google Scholar 

  120. Nash JA, Cohen SA. Gallbladder and biliary tract disease in aids. Gastroenterol Clin N Am. 1997;26:323–35.

    CAS  Google Scholar 

  121. Bouche H, Housset C, Dumont J, Carnot F, Menu Y, Aveline B, et al. Aids-related cholangitis: diagnostic features and course in 15 patients. J Hepatol. 1993;17:34–9.

    CAS  Google Scholar 

  122. Benhamou Y, Caumes E, Gerosa Y, Cadranel JF, Dohin E, Katlama C, et al. Aids-related cholangiopathy. Dig Dis Sci. 1993;38:1113–8.

    CAS  Google Scholar 

  123. Suzuki K, Morise Z, Furuta S, Tanahashi Y, Takeura C, Kagawa T, et al. Hepatic sarcoidosis mimicking hilar cholangiocarcinoma: case report and review of the literature. Case Rep Gastroenterol. 2011;5:152–8.

    Google Scholar 

  124. Alam I, Levenson SD, Ferrell LD, Bass NM. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis: case report and review of the literature. Dig Dis Sci. 1997;42:1295.

    CAS  Google Scholar 

  125. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988;12:708–15.

    CAS  Google Scholar 

  126. Murray KF, Larson AM. Fibrocystic diseases of the liver. Humana Press; 2010.

    Google Scholar 

  127. Coakley FV. Pearls and pitfalls in abdominal imaging: pseudotumors, variants and other difficult diagnoses. Cambridge, UK: Cambridge University Press; 2010.

    Google Scholar 

  128. Gibson RN, Sutherland T. Biliary anatomy. In: Grainger & Allison’s diagnostic radiology: abdominal imaging; 2015. p. 193.

    Google Scholar 

  129. Salihefendić N, Licanin Z, Zildzić M. Cavernous transformation of portal vein. Med Arh. 2005;59:132–4.

    Google Scholar 

  130. Majid Z, Tahir F, Bin Arif T, Ahmed J. Chronic non-cirrhotic portal vein thrombosis with cavernous transformation secondary to protein c and s deficiency. Cureus. 2020;12:e7142.

    Google Scholar 

  131. Altun E, El-Azzazi M, Semelka RC, Braga L, Altun E, El-Azzazi M, et al. Liver imaging: MRI with CT correlation. Wiley: Somerset; 2015.

    Google Scholar 

  132. Greiner L, Nuernberg D, Schmidt G, Nuernberg D. Differential diagnosis in ultrasound imaging. New York: Thieme Medical Publishers, Incorporated; 2014.

    Google Scholar 

  133. Moomjian LN, Winks SG. Portal cavernoma cholangiopathy: diagnosis, imaging, and intervention. Abdom Radiol. 2017;42:57–68.

    Google Scholar 

  134. De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with doppler sonography. AJR Am J Roentgenol. 1995;165:1151–5.

    Google Scholar 

  135. Bialecki ES, Di Bisceglie AM. Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:485–9.

    Google Scholar 

  136. Kim TK, Lee E, Jang HJ. Imaging findings of mimickers of hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:326–43.

    Google Scholar 

  137. Jang K-T, G-h A, Heo J-S, Choi D-I, Oh Y-L, Choi S-H, et al. Adenomyoma of ampulla of vater or the common bile duct-a report of three cases. Korean J Pathol. 2005;39:59–62.

    Google Scholar 

  138. Mulla M, Srivastava V, Hopper I, Klein J, Larvin M, Hall R. Diagnosis of biliary adenomyomatosis. Eur Surg. 2008;40:81–2.

    Google Scholar 

  139. Zimmermann A. Reactive bile duct alterations mimicking biliary cancer: Inflammatory conditions. In: Tumors and tumor-like lesions of the hepatobiliary tract: general and surgical pathology. Cham: Springer International Publishing; 2017. p. 2533–49.

    Google Scholar 

  140. Aoun N, Zafatayeff S, Smayra T, Haddad-Zebouni S, Tohme C, Ghossain M. Adenomyoma of the ampullary region: imaging findings in four patients. Abdom Imaging. 2004;30:86–9.

    Google Scholar 

  141. Handra-Luca A, Terris B, Couvelard A, Bonte H, Flejou J-F. Adenomyoma and adenomyomatous hyperplasia of the vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases. Mod Pathol. 2003;16:530–6.

    Google Scholar 

  142. Zimmermann A. Extrahepatic cholangiocarcinoma: carcinoma of the middle and distal common bile duct (middle and lower bile duct carcinomas). In: Tumors and tumor-like lesions of the hepatobiliary tract. Cham: Springer International Publishing; 2016. p. 1–21.

    Google Scholar 

  143. Dumonceau J-M, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers-part 1. Ther Adv Gastroenterol. 2020;13:1756284820927292.

    CAS  Google Scholar 

  144. Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: an overview. J Gastrointest Oncol. 2011;2:168.

    Google Scholar 

  145. Mizrahi M, Cohen J, de Andrade Lima JGG, Pleskow D. Malignant biliary obstruction: distal. In: ERCP. Elsevier; 2019. p. 372–84. e374.

    Google Scholar 

  146. Coletta M, Montalti R, Pistelli M, Vincenzi P, Mocchegiani F, Vivarelli M. Metastatic breast cancer mimicking a hilar cholangiocarcinoma: case report and review of the literature. Springer Nature, Cham Switzerland: World J Surg Oncol. 2014;12:384.

    Google Scholar 

  147. Nemunaitis JM, Brown-Glabeman U, Soares H, Belmonte J, Liem B, Nir I, et al. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer. 2018;18:665.

    Google Scholar 

  148. Barnes D. Gallbladder and biliary tract disease. Cleveland Clinic; 2010.

    Google Scholar 

  149. Goodman ZD, Ishak KG. Xanthogranulomatous cholecystitis. Philadelphia PA: Am J Surg Pathol. 1981;5:653–9.

    Google Scholar 

  150. Singh VP, Rajesh S, Bihari C, Desai SN, Pargewar SS, Arora A. Xanthogranulomatous cholecystitis: what every radiologist should know. World J Radiol. 2016;8:183.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thomas Jefferson University, Philadelphia, PA, USA

    Tina Boortalary & David Loren

Authors
  1. Tina Boortalary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Loren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Loren .

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Boortalary, T., Loren, D. (2022). Diagnosis and Evaluation of Cholangiocarcinoma. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation